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Abstract
Despite its demonstrated effectiveness, colorectal cancer (CRC) testing is suboptimal, particularly 
in vulnerable populations such as those who are publicly insured. Prior studies provide an 
incomplete picture of the importance of the intersection of multilevel factors affecting CRC testing 
across heterogeneous geographic regions where vulnerable populations live. We examined CRC 
testing across regions of North Carolina by using population-based Medicare and Medicaid claims 
data from disabled individuals who turned 50 years of age during 2003–2008. We estimated 
multilevel models to examine predictors of CRC testing, including distance to the nearest 
endoscopy facility, county-level endoscopy procedural rates, and demographic and community 
contextual factors. Less than 50% of eligible individuals had evidence of CRC testing; men, 
African-Americans, Medicaid beneficiaries, and those living furthest away from endoscopy 
facilities had significantly lower odds of CRC testing, with significant regional variation. These 
results can help prioritize intervention strategies to improve CRC testing among publicly insured, 
disabled populations.
☆The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the 
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1. Introduction
Colorectal cancer (CRC) is the third most common cancer diagnosis and the second leading 
cause of cancer death in the United States (Jemal et al., 2013). CRC is burdensome to human 
health and to the financial health of the health care system; total costs of caring for patients 
diagnosed with CRC in the United States are estimated to be more than $14 billion per year 
(Mariotto et al., 2011). Routine screening for CRC among those aged 50–75 years can 
reduce the financial burden of CRC, as well as reduce incidence and death caused by CRC 
(Pignone et al., 2002). Studies suggest that several different screening test regimens (annual 
high-sensitivity Fecal Occult Blood Test [FOBT]; combination of high-sensitivity FOBT 
every 3 years and sigmoidoscopy every 5 years; or colonoscopy every 10 years) are nearly 
equally effective in reducing CRC incidence and death if patients adhere to one of the 
regimens (Zauber et al., 2008; Whitlock et al., 2008; Pignone et al., 2002; Levin et al., 
2008). Importantly, CRC testing is cost-effective and with rising costs associated with 
treating advanced CRC, routine testing may lead to more timely detection of early stage 
cancers and become cost-saving (Lansdorp-Vogelaar et al., 2009).
Despite its demonstrated effectiveness, CRC test use is suboptimal. Overall, CRC testing has 
increased since 2002, but current rates remain modest, with just 64.5% of age-eligible US 
adults being up-to-date with CRC testing in 2010 on the basis of self-reported data in the 
CDC Behavioral Risk Factor Surveillance Survey (BRFSS) (Joseph et al., 2012). Although 
overall rates have increased during recent years, the likelihood of being up-to-date with CRC 
testing is particularly low for those living in non-metropolitan areas (65% versus 69% in 
metropolitan areas), those with low educational attainment (45% for less than high school 
graduates vs. 72% for college graduates); those with low household income (48% for 
incomes less than $15,000 per year vs. 74% for incomes more than $75,000 per year); 
minorities (52–65% for minorities vs. 66% for white adults); and those without a regular 
health care provider (32% for persons without a regular care provider vs. 68% for those with 
a regular care provider) (Joseph et al., 2012). As such, CRC testing has become an important 
health care disparity issue.
Myriad factors influence disparities in CRC testing, including individual-level, community-
level, and health care system-level factors (Klabunde et al., 2005). Many of these factors 
operate on multiple levels; for example, an individual’s minority race and whether s/he lives 
in a community with a more dense population of minorities both can have individual and 
interactive impacts on health and healthcare services received (Subramanian et al., 2009). As 
such, consideration of how these multilevel influences entwine is critical to understanding 
the probable reasons for CRC test underuse among vulnerable populations and intervening 
in meaningful and effective ways. Multilevel factors affecting cancer screening decisions 
include: gender, race, age, inability to travel to access care, competing health and non-health 
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demands on time and energy, rates of local poverty, unemployment, and uninsurance (all of 
which affect availability of and access to health services), geographic barriers to care (e.g., 
living far away from an endoscopy center), absence of social support resources, (such as 
help with transportation), social isolation, provider unwillingness to accept publicly insured 
patients, limited resources to support high-quality decision making (such as patient 
navigation programs, reminder systems, screening registries, or scheduling systems), and 
absence of a preventive care infrastructure within the public health system (Zapka et al., 
2010, 2003; Honeycutt et al., 2013; Mobley et al., 2010; Stanley et al., 2013; Golden et al., 
2009; Pagan et al., 2008).
Prior studies provide an incomplete picture of the importance of the intersection of 
multilevel factors affecting CRC testing across heterogeneous geographic regions where 
vulnerable populations live (Morrissey et al., 2012). Conducting rigorous multilevel analyses 
may help guide future resource allocation and community-based interventions to improve 
CRC testing among diverse communities with high numbers of publicly insured and 
medically vulnerable individuals.
Our research fills an important gap in the literature by reporting on the relative influence of 
individual-level and community-level predictors of CRC testing in North Carolina, (where 
community-level factors are operationalized at the county level) among Medicaid and 
Medicare enrollees turning 50 years of age. Because of eligibility criteria associated with 
Medicare and Medicaid enrollment, most 50-year-olds enrolled in Medicaid or Medicare in 
North Carolina are living with some type of disability and, thus, represent a particularly 
vulnerable population. Even with health insurance, disparities persist in receipt of cancer 
screening and other preventive services among people with disabilities. In a sample of 835 
disabled women between the ages of 51–65 years, Wei et al. (2006) found that only 28.7% 
of women with public insurance pursued CRC testing, whereas 48.6% of women with 
private insurance were tested for CRC. Disability has also been found to be associated with 
many chronic conditions, including obesity, cancer, poor mental health, diabetes, heart 
disease, hypertension, and asthma (Wei et al., 2006) as well as an overall shorter cancer 
survival rate (McCarthy et al., 2007). In addition, persons living with disabilities are 
generally less compliant overall with cancer screening guidelines (Ramirez et al., 2005; 
Armor et al., 2009) Therefore, disabled individuals may be a particularly vulnerable 
subpopulation for CRC testing, even when they have access to insurance. Understanding in 
greater detail the multilevel determinants of CRC testing among vulnerable populations, 
such as those living with disabilities, can help elucidate which targeted interventions are 
most likely to be successful in increasing CRC testing rates among these groups.
2. Methods
2.1. Overview
We sought to understand differences in relative rates of CRC testing across North Carolina’s 
publicly insured population and identify areas of need, focusing on individual and county 
level predictors of CRC testing among people turning 50 years of age, the age group for 
which the US Preventive Services Task Force (USPSTF) recommends initiating routine CRC 
testing (USPSTF, 2008). Accordingly, we used insurance claims data from North Carolina 
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Medicare and Medicaid linked to Area Resource File (ARF) and State Medical Facilities 
Plan (SMFP) data to examine multilevel determinants of CRC testing, including individual 
demographics, distance to endoscopy, availability of certain types of health care providers, 
and area-level poverty, education, unemployment, and racial composition. We estimated 
multilevel models with county level random effects and created county-specific maps 
depicting relative differences in multivariable-adjusted predicted probabilities of CRC 
testing.
2.2. Data
We acquired Medicaid and Medicare claims data from 2003 to 2008 for the population of 
North Carolina insured by either or both of these public insurance providers, providing us 
with substantial individual-level data about CRC testing. Geographic and health care service 
provider data from two additional sources were linked to the individual claims data by using 
county and ZIP code of residence. First, we used the ARF to incorporate county-specific 
sociodemographic and health care workforce information into our analyses. The ARF is 
frequently used to describe county level community contextual factors, such as income 
levels, employment status, and rural land. The ARF database is a collection of data from 
more than 50 sources, including the American Medical Association, the US Census Bureau, 
and the Centers for Medicare & Medicaid Services, and has more than 6000 county 
aggregate variables, including health measures. These data have been used frequently in 
prior studies of CRC testing (Hayanga et al., 2010; Koroukian et al., 2005, 2006). Second, 
we used historical SMFP data to identify endoscopy centers across the state and called each 
of these centers to verify information contained in the archived SMFP records, including, but 
not limited to, facility street addresses, (which were needed for geocoding), affiliate facilities 
(where applicable), and procedures performed. This information enabled us to calculate 
distance to nearest endoscopy center and to estimate annual county level endoscopy 
procedural rates.
2.3. Population and inclusion/exclusion criteria
The population of interest is publicly insured men and women living in North Carolina who 
turned 50 years of age during 2003–2008, reflecting current age-specific screening 
recommendations (USPSTF, 2008). Because guidelines differ on frequency of CRC testing 
by modality (USPSTF, 2008) (e.g., colonoscopy every 10 years, FOBT every year, flexible 
sigmoidoscopy every 5 years with FOBT every 3 years), we focused our analyses on 
tracking incident CRC testing within a cohort of individuals in North Carolina who were 
newly age-eligible. Importantly, given that these people were turning 50 years of age during 
our study period and insured by Medicare and/or Medicaid, and because of eligibility 
criteria associated with Medicare and Medicaid in North Carolina, more than 99% of the 
individuals in the sample were living with some type of disability and thus, were a 
particularly vulnerable population.
To ensure complete claims, we included only beneficiaries who were residents of North 
Carolina with valid ZIP code and county data, continuously enrolled in non-HMO plans, and 
alive for the entire duration of the 6-year study period, enabling the systematic examination 
of CRC testing practices at the individual level during multiple years. To better ensure that 
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our measures reflected screening test procedures rather than surveillance procedures for 
persons with past history of CRC, we excluded those beneficiaries with a history of CRC or 
colectomy. Because of the importance of county level factors in our analyses, we excluded a 
minority of beneficiaries who moved across county lines during the study period. Finally, a 
small number of individuals who had end stage renal disease (ESRD), and a very small 
minority of beneficiaries who were enrolled in Medicare and/or Medicaid for eligibility 
reasons other than disability (N=427; <1%) were excluded, leaving us with a final analytic 
sample of 27,178 individuals with 6 years of complete claims data (see Fig. 1).
2.4. Dependent variable
Our primary outcome measure was a binary indicator of whether the person received any 
type of CRC screening test procedure, including colonoscopy, FOBT, or flexible 
sigmoidoscopy, during the study period. Colonoscopy, FOBT, and flexible sigmoidoscopy 
were measured as separate procedures, each potentially indicating that screening was 
performed, consistent with USPSTF guidelines; subsequent follow-up and diagnostic 
procedures were not assessed. Dates of services were recorded for each procedural code of 
interest, identified by International Classification of Diseases, 9th Edition, Clinical 
Modification (ICD-9-CM), Current Procedural Terminology (CPT), or Healthcare Common 
Procedure Coding System (HCPCS) codes. The codes used are summarized in Table 1.
2.5. Independent variables
Independent variables of interest included individual-level characteristics, such as gender 
(male or female), race (white, black, or other), types of insurance (i.e., Medicare-only, 
Medicaid-only, or dually enrolled), year turned 50, and distance from patient ZIP code to 
nearest endoscopy facility. The latter was calculated by identifying all endoscopy facilities in 
North Carolina by using the 2007 SMFP Inventory of Endoscopy Rooms in Licensed 
Facilities; this documentation provides the facility name and county, number of rooms, as 
well as procedural rates in each year. Each of the 178 facilities across North Carolina’s 100 
counties was telephoned to obtain the physical address of the facility, verify the facility was 
in operation during the entire study period, and identify whether that facility operated with 
other group practices or was affiliated with a hospital. By using the beneficiaries’ residential 
ZIP code and the facilities’ actual physical address, we geocoded these locations to obtain 
X/Y coordinates by using ArcGIS Desktop Release 10.0 (Environmental Systems Research 
Institute, Redlands, CA, 2011). These coordinates were then used to calculate the straight-
line distance from the ZIP code centroid of each beneficiary to each endoscopy facility 
throughout the state. By rank-ordering these distances, we were able to identify the nearest 
endoscopy facility to each beneficiary, employing a previously published approach (Wheeler 
et al., 2012). Distances to nearest endoscopy facility were further categorized as follows for 
subsequent analyses: less than 5 miles, 5–10 miles, 10–15 miles, 15–20 miles, 20–25 miles, 
and 25 or more miles.
Additional independent variables were county level characteristics derived from the ARF 
data, including a population-adjusted count of medical generalists (adjusted for the 
population of Medicaid/Medicare enrollees living in the county and dichotomized at the 
median for analyses), percentage living below the federal poverty line, percentage with less 
Wheeler et al. Page 5
Health Place. Author manuscript; available in PMC 2018 February 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
than a high school education, percentage unemployed, percentage uninsured, and percentage 
non-white. The latter five variables were categorized into quartiles. Finally, the SMFP data 
reported the total number of inpatient endoscopy cases, ambulatory endoscopy cases, and 
total endoscopy procedures performed annually. We used the latter measure (total endoscopy 
procedures performed) to create a county level measure of annual endoscopy procedural 
rates per 10,000 residents. Counties without any endoscopy center as reported by the SMFP 
(N=28) were assigned a value of zero for endoscopy procedural rate.
2.6. Statistical analyses
We stratified our analyses on the basis of insurance type (Medicare only, Medicaid only, or 
dually enrolled in Medicaid and Medicare for any time during our study period) because 
these three groups of beneficiaries are likely quite different from one another in important 
unmeasured ways because of eligibility criteria for these public entitlement programs. (For 
example, Medicaid enrollees must demonstrate their low income status and meet one of the 
several additional criteria of vulnerability; Medicare enrollees do not have to demonstrate 
low income status, but they must meet other criteria for enrollment.) (Assistance, 2013; 
Medicare.gov, 2012). In addition, in pooled analyses, overall use of CRC testing and the 
magnitude and significance of factors affecting CRC testing varied significantly by 
beneficiary group.
Baseline descriptive characteristics of the sample were examined first. We used Chi2 and t-
test statistics to describe the relationships between receipt of CRC testing and independent 
variables in bivariate analyses. Given the clustering of beneficiaries at the county level, we 
used multilevel multivariable logistic models to examine variation in CRC testing, 
controlling for individual (e.g., gender, race, distance to endoscopy) and county level (e.g., 
number of procedures performed at the county level per 10,000 persons per year) 
characteristics. We allowed the intercept to vary at the county level (e.g., we estimated a 
random intercepts model). The equation can be described as follows:
where πij is the probability of the binary outcome (CRC testing) for person i living in county 
j, β0j is the intercept for county j, β1 is the coefficient for the person-level predictor Age, β2 
is the coefficient for the person-level predictor Race, βp+1 is the coefficient for the county 
level predictor Procedural Rate in county j, βp+2 is the coefficient for the county level 
predictor Generalist in county j, and eij is the error term.
Interaction terms were considered to examine possible joint effects of individual variables 
(e.g., gender and race), but because of a lack of statistical significance and improvement of 
model fit, these interactions were not included in the final model estimations.
Final models were used to derive average predicted probabilities of CRC testing for each 
county in North Carolina. From these multivariable adjusted county-specific predicted 
probabilities, we categorized predictions into tertiles across the 100 North Carolina counties 
and generated maps illustrating differences in predictions by tertiles. The maps also depict 
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the number of endoscopy centers in each county, as well as the nine largest cities in North 
Carolina designated as urban centers (with population sizes more than 100,000). All 
statistical analyses were conducted in SAS software (version 9.2; SAS Institute, Inc., Cary, 
North Carolina). Maps were created by using ArcGIS Desktop Release 10.0 (Environmental 
Systems Research Institute, Redlands, CA, 2011).
3. Results
Of the 27,178 individuals included in our sample, 45% were male, and 56% were white 
(Table 2). For insurance type, 26% of beneficiaries were enrolled in Medicare only, 24% 
were enrolled in Medicaid only, and 50% were dually enrolled at some point during the 
study period. Medicare-only enrollees were predominantly male and white, whereas 
Medicaid-only enrollees were predominantly female and black. Of those individuals dually 
enrolled in Medicaid and Medicare, 52% were female and 56% were white. Nearly half of 
our sample lived within 5 miles of an endoscopy facility, but more than 25% of the sample 
lived more than 10 miles away from the nearest endoscopy facility, with 422 individuals 
living more than 25 miles away from the nearest endoscopy facility.
Fig. 2 is a map of North Carolina depicting numbers of endoscopy facilities in each county. 
Mecklenburg and Wake counties have the most endoscopy facilities (17 and 12, 
respectively), whereas 28 counties have none. County level endoscopy volume procedural 
rates ranged from 0 to 1462 endoscopies performed annually per 10,000 residents, where 
darker red shading reflects fewer endoscopy procedures performed at the county level and 
lighter pink shading reflects more endoscopy procedures performed at the county level. The 
color of shading (i.e., red, orange, yellow) indicates the density of the study population (i.e., 
publicly insured 50-year-olds) as a function of the general population (per 10,000 residents) 
living in the county, where red indicates greater density of publicly insured individuals and 
yellow indicates lower density of publicly insured individuals. From this map, it is clear that 
several counties (particularly in the northeastern, western, and southeastern regions of the 
state) contain the greatest density of publicly insured 50-year-olds and that those individuals 
have poorest access to endoscopy facilities. This map indicates significant variation in access 
to endoscopy, endoscopy procedural rates across counties, and in the distribution of our 
study population across counties.
Overall, according to the insurance claims data, 49% of our total sample received at least 
one CRC test during the 6-year study period, with 36% receiving at least one colonoscopy, 
25% receiving at least one FOBT, and less than 5% receiving other test modalities, such as 
CT colonography (results not shown). Table 3 presents results from the multilevel 
multivariable logit model with random effects and the adjusted odds ratios (OR) of predictor 
variables on the receipt of CRC testing, presented in total and stratified by insurance type 
(Medicare-only, Medicaid-only, or dual insurance). In the total sample, individuals insured 
by Medicaid only had significantly lower odds of having been tested for CRC compared 
with Medicare-only enrollees (OR: 0.86; 95% CI=0.79, 0.95). In the total sample, women 
had 2.15 greater odds of CRC testing (95% CI=2.04, 2.26) compared with men. In the 
Medicare-only stratified model, women had 2.65 greater odds of CRC testing (95% CI=2.38, 
2.94) (Table 3).
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In the total sample, living more than 25 miles from an endoscopy facility was associated 
with 0.78 times the odds of CRC testing compared with those living 0–5 miles from a 
facility (95% CI=0.63, 0.96); this finding appeared to be entirely driven by the Medicaid-
only sample, as the distance-to-endoscopy effect was even more pronounced in the 
Medicaid-only analytic stratum (even at the 15–20 mile level), whereas distance-to-
endoscopy was not a statistically significant predictor in the Medicare-only or dual stratified 
analytic models.
In general across the insurance strata, African-American individuals had lower odds of CRC 
testing, with little variation in the magnitude of effect across insurance-stratified models: 
Medicare-only (OR=0.83, 95% CI=0.74, 0.94), Medicaid-only (OR=0.88, 95% CI=0.78, 
0.99), and dual insurance (OR=0.89, 95% CI= 0.82, 0.97).
Finally, individuals insured by Medicare-only and Medicaid-only living in counties that 
performed more than 800 procedures annually had 1.54 and 1.39 higher odds of CRC 
testing, respectively, compared with those individuals who lived in counties without any 
CRC facility or 0 procedures performed (95% CI=1.07, 2.20, and 95% CI=1.01, 1.91, 
respectively). Importantly, for the Medicare-only stratum, higher endoscopy procedural rates 
(as compared with living in counties without any CRC facility or 0 procedures performed) 
corresponded to significantly higher odds of CRC testing at almost every procedural rate 
level.
Table 4 depicts the average predicted probabilities of receiving CRC testing on the basis of 
varying distance to the nearest endoscopy facility and calculated for a typical person in the 
sample with the following characteristics held constant: female; white; turned 50 years of 
age in 2003; resident of a county where the population-adjusted generalist count is above 
median, the population-adjusted endoscopic procedure rate is 1–200 in a given year, and the 
county is in the lowest quartile of high school education; percentage living in poverty; 
uninsurance rate; unemployment rate; and percentage non-white. In the total sample, 62% of 
individuals with these characteristics who lived 0–5 miles away from an endoscopy facility 
would be predicted to get tested for CRC, compared with 56% of those living 25 or more 
miles away from a facility. Individuals insured by Medicare only had the highest predicted 
probability of getting CRC testing: 73% when living 0–5 miles away from an endoscopy 
facility and 65% when living 25 or more miles from a facility. By contrast, only 59% of 
individuals insured by Medicaid were predicted to receive CRC testing when living 0–5 
miles away from an endoscopy facility compared with 51% of those living 25 or more miles 
away.
Fig. 3 shows four county-specific maps of North Carolina, detailing the adjusted, county-
specific predicted probabilities of CRC testing for the total sample (Fig. 3a), Medicaid 
insurance only (Fig. 3b), Medicare insurance only (Fig. 3c), and dual enrollment in 
Medicare and Medicaid (Fig. 3d). We calculated county-specific predicted probabilities by 
averaging the individual predicted probabilities from the final model for each county. A few 
interesting findings warrant discussion. First, Wake county (where Raleigh is located, the 
state capital, and second largest city in the state) and Mecklenburg county (where the state’s 
largest city, Charlotte, is located) have the highest concentrations of endoscopy facilities in 
Wheeler et al. Page 8
Health Place. Author manuscript; available in PMC 2018 February 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
the state, but relatively low predicted probabilities for CRC testing. Upon further 
examination of the maps stratified by insurance type, it is clear that these extremely low 
predicted probabilities are limited to the Medicaid and dual insured samples. For example, 
Fig. 3b and d shows that Wake county is in the lowest tertile (has the lowest predicted 
probability) for CRC testing among Medicaid-only patients (0.36–0.45) and among dual 
insured patients (0.43–0.48), but in Fig. 3c, individuals solely insured by Medicare in Wake 
county have a higher predicted probability of CRC testing (0.46–0.50). In addition and 
worth noting, across all of these maps, the predicted probabilities of CRC testing were 
consistently low in the westernmost counties of North Carolina (in the mountains) and 
among isolated counties in the eastern part of the state (near the coast). Other regions, 
including some northeastern counties and north-central counties, have few to no endoscopy 
facilities and low predicted probabilities for CRC testing across all Medicare, Medicaid, and 
dually insured populations.
4. Discussion
We analyzed Medicare and Medicaid data linked to ARF and SMFP data to understand CRC 
testing patterns and multilevel predictors of CRC testing among individuals turning 50 years 
of age during 2003–2008, the age at which CRC testing should commence, according to 
USPSTF guidelines. In particular, we were interested in regional variation in CRC testing 
rates and in geographic access to CRC testing across a large, diverse state. In other words, 
we sought to understand where there may be areas of opportunity according to CRC testing 
underuse, where there may be “endoscopy deserts” with poor access to endoscopy, and to 
what extent distance to endoscopy and county-specific factors were associated with receipt 
of CRC testing.
Our findings highlight a number of important preventive health issues. First, less than half of 
all newly eligible individuals in this publicly insured, disabled sample received any CRC 
testing during a 6-year study period, indicating poor use of preventive health care services. 
In general, this is slightly lower than what has previously been reported in national BRFSS 
data among similar age groups in the general population (Joseph et al., 2012; Stanley et al., 
2013). In addition, prior data have shown that approximately one-third of North Carolinians 
aged 50–75 years are not up-to-date with CRC screening (Joseph et al., 2012). Differences 
in our data as compared with other studies may be explained by underlying differences 
between our disabled population and the general population or by the self-reported nature of 
BRFSS, which may be subject to recall bias or social desirability bias. In contrast, our data 
are claims-based and, therefore, reflect actual services received and paid for by public 
insurers. On the other hand, our estimates may underestimate CRC testing rates because 
claims data capture services only if they were billed for reimbursement. Some FOBTs that 
were performed, for example, may not have been billed to insurance because of their low 
reimbursement rates, and our analysis cannot capture services not billed to and paid by 
Medicare and/or Medicaid. In addition, individuals who turned 50 years of age towards the 
end of our study period may have delayed but eventually had evidence of CRC testing after 
our study period ended—the implications of delaying guideline-recommended cancer testing 
for months or several years are unknown. Likewise, it is possible that a minority of 
individuals in our sample were screened before our data window began, (for example, if they 
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had a family history of CRC). Unfortunately, we were not able to capture such services if 
they happened before our observation period; nevertheless, we expect this to be a small 
number of people.
Second, we have shown significant heterogeneity in CRC testing across counties and among 
different types of publicly insured groups in North Carolina. Among Medicaid-only enrolled 
individuals, average predicted probabilities for CRC testing varied from 0.36 to 0.62 across 
counties, and among Medicare-only enrolled individuals, average predicted probabilities 
ranged from 0.24 to 0.61 across counties. Several counties were consistently poor 
performers for CRC testing, including counties in the western and north-central parts of the 
state, as well as several isolated counties in the eastern coastal regions. In many cases these 
poor performing counties had either no endoscopy facility or very low endoscopy rates, 
perhaps indicating “endoscopy deserts”, a supply-side problem. Importantly, some of the 
lowest predicted probabilities were observed in counties with the highest densities of 
endoscopy centers, such as Wake and Mecklenburg counties, indicating that availability of 
endoscopy centers alone does not lead to higher CRC testing uptake. This finding was even 
more pronounced in the Medicaid-only and dual-insured samples, perhaps reflecting 
providers’ unwillingness to accept Medicaid insurance in these endoscopy center-rich areas, 
or urban patients’ limited awareness of the benefits of CRC testing. This finding is 
consistent with some studies that have suggested urban disadvantages in cancer care 
(McLafferty and Wang, 2009; McLafferty et al., 2011), but different from other studies that 
have found rural areas to be most underserved (Cole et al., 2012, Meilleur et al., 2013).
For multilevel predictors of CRC testing in the total sample, men, African-Americans, 
Medicaid enrollees, and those individuals living more than 25 miles from an endoscopy 
facility had significantly lower odds of CRC testing. In addition, among Medicare-only 
enrollees and to a lesser extent, Medicaid-only enrollees, increasing county level endoscopy 
procedural rates were predictive of CRC testing. And among Medicaid enrollees in 
particular, living more than 25 miles away from an endoscopy center was associated with 
lower odds of CRC testing. We expected shorter distances of 10 miles or more to endoscopy 
centers to be significantly predictive of CRC testing, but did not find this to be the case in 
this North Carolina sample, which may reflect more willingness to travel for healthcare 
services or substitution of FOBT instead of colonoscopy for CRC screening among these 
individuals. Other findings, particularly those for men, African-Americans, and lower 
income (Medicaid-insured) individuals, are consistent with other studies conducted in 
different settings (Joseph et al., 2012). To our knowledge, this is one of the first studies to 
examine county-specific endoscopy procedural rates and distance between individual 
residence and endoscopy centers as potential predictors of CRC testing. Our extensive model 
specification testing (not detailed here) further justified and underscored the importance of 
using a multilevel, random effects model with county-specific intercepts for estimation. 
Studies not considering the multilevel influence of various relevant factors on CRC testing 
may be biased (Morrissey et al., 2012).
Despite the strengths of the overall approach, including the use of multilevel modeling and 
multiple large data set links, several important limitations accompany our findings. Although 
claims data have been shown to provide an accurate portrayal of CRC testing practices 
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(Schenck et al., 2007), there are limitations to analyses that use Medicare and Medicaid 
claims data, including the following: limited ability to directly assess patient-provider 
decision making in the absence of medical record reviews or patient-provider interviews; 
limited number of years available to validate that CRC testing as measured in the claims 
reflects whether individuals are up-to-date with screening; and inability to understand CRC 
testing patterns among the uninsured, and HMO-enrolled, and populations not continuously 
enrolled (i.e., excluded populations). Medicaid and Medicare claims data also cannot reflect 
services not covered or not reimbursed by Medicaid or Medicare, or services provided 
during a time in which the individual was ineligible or not enrolled in the entitlement 
program, so any services paid for out-of-pocket or by another third-party payer cannot be 
identified. This concern is particularly relevant for those excluded individuals transitioning 
in and out of the program month-to-month (most relevant for the Medicaid population), for 
whom we know nothing during the time when insurance coverage lapsed. Given this issue, 
our results may not be representative of those publicly insured populations whose coverage 
is transient over time. In addition, our data were unable to provide detailed health care 
system-level information that may affect CRC testing, such as additional endoscopy facility-
level information (e.g., number and qualifications of staff; quality of scheduling and 
outreach services; wait times) and community-level health educational, social support (e.g., 
transportation), and decision-making resources. Lastly, because individuals often cross 
county-lines to obtain healthcare, county level resource availability and numbers of 
endoscopy procedures performed in a single county may be imperfect measures of access to 
CRC screening. Future studies should consider identifying referral networks and clusters of 
cancer prevention services and characterizing preventive healthcare seeking behavior across 
county lines (for example, do patients bypass closer providers to obtain preventive services 
and how often and how far do they travel to other counties to obtain preventive services?) 
Regardless, it is possible to characterize relative differences in CRC testing rates at the 
individual and county levels and identify communities in North Carolina where publicly 
insured, disabled individuals eligible for CRC testing appear to be most underserved.
5. Conclusion
Our results suggest that receipt of CRC testing among publicly insured individuals across 
one socioeconomically and geographically diverse state is highly variable, and that certain 
vulnerable populations may be more at risk than others and, therefore, particularly suitable 
for intervention targeting. Interventions that may be most effective are perhaps those that 
help patients overcome transportation and other physical access barriers, (e.g., at-home 
testing by using stool sample kits that can be mailed to providers), or those that target 
African-Americans, males, and Medicaid-insured or low-income subgroups employing 
culturally competent approaches to improve awareness, patient-provider communication, 
and trust, (e.g., individualized patient navigation) (Dubard et al., 2008). For example, one 
such collaborative learning intervention implemented in federally qualified health centers led 
to increased clinical tracking and documentation and a 12.6% increase in CRC screening test 
uptake (Taplin et al., 2008). More broadly, considering that our study sample represented a 
disabled, medically vulnerable population, all of whom had lower rates of CRC testing than 
expected as compared with general populations, tailoring CRC testing interventions to all 
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publicly insured individuals in this age group may be an important prevention strategy. 
Although the Community Guide task force recommendations (Taskforce, 2012) are useful 
and broadly applicable among the general population, they may not be as responsive to the 
unique needs of vulnerable populations. In addition, because multiple colorectal cancer 
testing modalities create a preference-sensitive decision-making environment, it is important 
to understand preferences for CRC testing among vulnerable populations. Understanding the 
CRC-related decisions and preferences made by vulnerable and hard-to-reach populations 
will likely improve CRC testing rates over time among the most at-risk groups.
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Fig. 1. 
Inclusion or exclusion criteria applied to generate analytic sample. Notes: CRC (colorectal 
cancer); ESRD (end state renal disease); HMO (Health Maintenance Organization); NC 
(North Carolina); ZIP (Zone Improvement Plan).
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Fig. 2. 
County-specific location of endoscopy facilities, endoscopy procedural rates, density of 
Medicare and Medicaid beneficiaries, and major urban cities in North Carolina. Notes: this 
map was generated by using 2007 data from the State Medical Facilities Plan (SMFP) about 
the location and endoscopy procedural rates throughout North Carolina. The total number of 
endoscopy centers in each county is indicated in the center of each county. County level 
endoscopy procedural rates ranged from 0 to 1462 endoscopies performed annually per 
10,000 residents, where darker shading reflects fewer endoscopy procedures performed at 
the county level and lighter shading reflects more endoscopy procedures performed at the 
county level. The color of shading (i.e., red, orange, yellow) indicates the density of the 
study population (i.e., publicly insured 50-year-olds) as a function of the general population 
(per 10,000 residents) living in the county, where red indicates greater density of publicly 
insured individuals and yellow indicates lower density of publicly insured individuals. (For 
interpretation of the references to color in this figure legend, the reader is referred to the web 
version of this article.)
Wheeler et al. Page 16
Health Place. Author manuscript; available in PMC 2018 February 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 3. 
Multivariable-adjusted predicted probabilities of colorectal cancer testing by county. Panel a: 
total sample (all insurance providers). Panel b: Medicaid-only sample, Panel c: Medicare-
only sample, and Panel d: dually insured by Medicaid and Medicare sample. Notes: these 
maps depict multivariable-adjusted regional variation by county in individual colorectal 
cancer testing during a 6-year period among people turning 50 years of age who were 
publicly insured during 2003–2008 (panel a: all providers; panel b: Medicaid only; panel c: 
Medicare only; and panel d: dually insured by Medicaid and Medicare). Shading reflects 
county-specific predicted probabilities in tertiles, as generated from multivariable models. 
Predicted probabilities were calculated by averaging the individual predicted probabilities 
from the final model for each county. Increasingly darker red shading indicates lower levels 
of CRC testing across the state, whereas increasingly lighter pink shading indicates higher 
levels of CRC testing across the state, controlling for all other person-level and county level 
factors. Major urban cities (more than 100,000 persons) are designated by callouts, and 
numbers indicate the count of endoscopy centers in each county. In panel 3b, the lack of any 
eligible beneficiaries in the 5-county Piedmont area consisting of Cabarrus, Davidson, 
Rowan, Stanley, and Union (shaded in gray) is indicative of a special, prepaid managed care 
plan operating in the Piedmont Behavioral Healthcare catchment area during the study 
period. As such, we excluded Medicaid-only beneficiaries in this region due to special 
program features operating in that region. (For interpretation of the references to color in 
this figure legend, the reader is referred to the web version of this article.)
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Table 1
Billing codes indicating colorectal cancer testing procedures.
Screening test modality Codes
Fecal occult blood test (FOBT) 82270, 82272, 82273, 82274, G0328, G0107
Colonoscopy 44388, 44389, 44392, 44393, 44394, 44397, 45355, 45378, 45379, 45380, 45381, 45382, 45383, 45384, 
45385, 45392, G0105, G0121, 45.21, 45.22, 45.23, 45.25, 45.41, 45.43, 48.36
Flexible sigmoidoscopy 45300, 45303, 45305, 45307, 45308, 45309, 45315, 45317, 45320, 45321, 45327, 45330, 45331, 45332, 
45333, 45334, 45335, 45337, 45338, 45339, 45340, 45341, 45342, 45345, G0104, 45.24, 48.21, 48.22, 48.23, 
48.24
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Table 4
Predicted probabilities of receiving CRC testing by distance to nearest endoscopy facility, calculated for a 
typical individual in a sample, stratified by insurance type.
Distance Predicted probability
Total Medicare only Medicaid only Dual
0–5 Miles 0.620 0.731 0.587 0.567
>5–10 Miles 0.614 0.713 0.569 0.578
>10–15 Miles 0.617 0.730 0.569 0.574
>15–20 Miles 0.602 0.728 0.531 0.572
>20–25 Miles 0.650 0.782 0.617 0.574
25+ Miles 0.561 0.654 0.506 0.517
% Point difference between categories: 0–5 miles and 25+ miles 6.0% 7.6% 8.1% 5.1%
*
Modal sample for total cohort includes individuals with the following characteristics: female, white, Medicare only beneficiary, turned 50 years of 
age in 2003, and resident of a county where: population-adjusted generalist count is above median, population-adjusted endoscopic procedural rate 
is 1–200 in a given year, and county is in the lowest quartile of (1) high school education, (2) percentage poverty, (3) uninsurance rate, (4) 
unemployment rate, and (5) percentage non-white.
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